A carregar...

A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges

10–15% of invasive epithelial ovarian cancer is attributable to hereditary breast and ovarian cancer. The identification of BRCA1/BRCA2 mutations in women with ovarian cancer allows for accurate predictive genetic testing of their at-risk relatives, who can then avail themselves of early detection a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Fam Cancer
Main Authors: Daniels, Molly S., Burzawa, Jennifer K., Brandt, Amanda C., Schmeler, Kathleen M., Lu, Karen H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4286250/
https://ncbi.nlm.nih.gov/pubmed/21246292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10689-011-9418-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!